|Bid||49.02 x 0|
|Ask||49.04 x 0|
|Day's Range||44.57 - 49.14|
|52 Week Range||8.36 - 49.14|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||46.83|
These Canadian marijuana stocks shot higher on no news. But there's a likely reason behind their big moves.
CORAL GABLES, FL / ACCESSWIRE / August 20, 2018 / Typically the industry for marijuana stocks is quiet during the summer months. This year, however, has seen a surge in pot stocks during late August. As the legalization of recreational marijuana in Canada looms, some blue-chip companies have taken notice.
The market gave the deal a thumbs-down, but there's good reason to think it will pay off in the long run.
Alcoholic beverage producer Constellation Brands, Inc. (NYSE: STZ ) is trading at a notable valuation premium to the broader market which can't be justified — especially after its $4-billion investment ...
Last week was broadly positive for the cannabis sector at last. The Horizons Marijuana Life Sciences ETF (HMMJ) rose ~4.6% from its closing on August 10 to its closing on August 17, while the Emerging Marijuana Growers Index ETF (HMJR) rose by 1.7% over the week.
U.S.-listed shares of Canada-based Canopy Growth Corp. soared almost 30% Wednesday, after liquor seller Constellation Brands Inc. said it will invest another CAD $5 billion, or about $4 billion, in the diversified cannabis company.
CORAL GABLES, FL / ACCESSWIRE / August 17, 2018 / Excitement continues to build around Canada's move for legal recreational marijuana sales coming up in October. The country's medical marijuana policy has been in place for a long time now and with this latest push to become the first G7 nation to legalize pot for recreational retail sales, questions have begun to surface about what the next steps for the US will be. Canopy Growth (CGC) (WEED.TO) reportedly said it would be able to "move ahead" into the U.S. if legislation were in place preventing the federal government from interfering with state cannabis policies, as marijuana stocks eye a potentially friendlier U.S. market.
Canopy Growth Corp (NYSE: CGC ) announced Wednesday its beverage company partner Constellation Brands, Inc. (NYSE: STZ ) is increasing its stake in the company to 38 percent. The Analyst Canaccord Genuity's ...
Canopy Growth, Cronos Group, and Tilray have captured the imagination of growth investors. But can the blistering growth of their share prices continue, or is it time to take profits?
Previously in this series, we discussed the target price upgrades for Canopy Growth (WEED) (CGC) from PI Financial and Canaccord Genuity. In this part, we’ll discuss two more upgrades on August 16.
Could another huge deal be on the way after Constellation's $4 billion investment in Canopy? Investors seem to think so.
Canopy Growth (WEED) (CGC), the biggest cannabis producer in terms of capacity, released its earnings on August 14. On August 15, Canopy Growth stock rose as much as 30% on news that Constellation Brands (STZ) pumped ~$4 billion into the company. With these positive catalysts, Canopy Growth received target price upgrades from four firms.
Orgenesis (ORGS) is an underfollowed player in the biotech sector, but with growing revenue and high-profile clients and partners. Most recently, a prestigious healthcare institute Great Point Partners invested up to $25 million directly in their subsidiary and is acting as a key advisor for their global business expansion. Fundamentals are looking good at ORGS as revenue climbed 73% in fiscal Q2, over the year-ago period.
Constellation Brands, Inc. Class A (NYSE: STZ ) announced Wednesday an agreement to augment its stake in Canopy Growth Corp (NYSE: CGC ) from 9.9 percent to 38 percent. The Analyst Reviewing the transaction, ...
Don't underestimate just how big of a deal Constellation's expanded investment in Canopy is.